Rigel Pharmaceuticals Inc. (RIGL) Company Report Aug. 02, 2022, 13:12 UTC 37 New SEC Form for Rigel Pharmaceuticals, Inc. Comment Full text
Rigel Pharmaceuticals Inc. (RIGL) Company Report Aug. 02, 2022, 13:03 UTC 38 Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update Comment Full text
Rigel Pharmaceuticals Inc. (RIGL) Company Report Aug. 02, 2022, 13:02 UTC 38 Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid Leukemia Comment Full text
Esperion Therapeutics Inc. (ESPR) Company Report Aug. 02, 2022, 05:57 UTC 34 New Form 10-Q for Esperion Therapeutics, Inc. Comment Full text
Sage Therapeutics Inc (SAGE) Company Report Aug. 02, 2022, 04:27 UTC 59 New Form 10-Q for Sage Therapeutics Inc Comment Full text
ImmunoGen Inc (IMGN) Company Report Aug. 01, 2022, 13:12 UTC 37 New Form 10-Q for ImmunoGen, Inc. Comment Full text
Incyte Corporation (INCY) Company Report July 29, 2022, 14:55 UTC 39 Weekly Summary Alert for Incyte Corporation Comment Full text
Ultragenyx Pharmaceutical Inc. (RARE) Company Report July 29, 2022, 03:10 UTC 40 New Form 10-Q for Ultragenyx Pharmaceutical Inc. Comment Full text
Seagen Inc (SGEN) Company Report July 28, 2022, 13:04 UTC 40 Seagen - Second Quarter 2022 Comment Full text